Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

UPDATE 5-Oil gains on storm-hit U.S. output and COVID-19 treatment hopes

Mon, 24th Aug 2020 04:21

* Storms shut 58% of U.S. Gulf of Mexico oil output

* Trump considers fast-tracking COVID-19 vaccine - FT

* U.S. drillers add rigs for the first time since March
(Updates prices, adds Motiva refinery closure)

By Bozorgmehr Sharafedin

LONDON, Aug 24 (Reuters) - Crude oil prices rose on Monday
as storms closed in on the Gulf of Mexico, shutting more than
half its oil production, and on signs of progress in development
of a COVID-19 treatment.

Brent crude was up 37 cents, or 0.8%, at $44.72 a
barrel by 1313 GMT. U.S. West Texas Intermediate crude
rose 18 cents, or 0.4%, to $42.52.

"Prices are taking their cues from Mother Nature this
morning as two storms bear down on the Gulf of Mexico. Half of
the region's production has been shut down, though gains will be
limited by the threat of a second prolonged COVID wave," said
Stephen Brennock of oil broker PVM.

Energy companies shut more than 1 million barrels per day
(bpd) of offshore crude oil production in the U.S. Gulf of
Mexico because of the twin threat from Hurricane Marco and
Tropical Storm Laura. Workers have been evacuated from more than
100 production platforms.

"While there is a focus on oil production at the moment, we
will need to keep an eye on refining activity, which is
vulnerable to flooding. The U.S. Gulf is a key refining hub,"
said Warren Patterson, ING's head of commodities strategy.

Motiva Enterprises may shut the largest crude oil
refinery in the United States for the bad weather later this
week, according to sources.

Also supporting prices was a report by the Financial Times
that U.S. President Donald Trump is considering fast-tracking an
experimental COVID-19 vaccine being developed by AstraZeneca
and Oxford University.

On Sunday Trump also hailed FDA authorization of a
coronavirus treatment that uses blood plasma from recovered
patients, a day after he accused the agency of impeding the
rollout of vaccines and therapeutics for political
reasons.

Oil price gains were kept in check, however, by an increase
in the U.S. oil and natural rig count for the first time since
March, with the addition of the most oil rigs in seven months as
shale producers resume drilling.

(Reporting by Bozorgmehr Sharafedin in London
Additional reporting by Jessica Jaganathan in Singapore
Editing by David Goodman and David Evans)

Related Shares

More News
Today 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announ...

3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.